General Information of the Compound
Compound ID
CP0850853
Compound Name
(3aR,9bS)-6-chloro-2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-one hydrochloride
    Show/Hide
Structure
Formula
C11H12Cl2N2O
Molecular Weight
259.136
Canonical SMILES
Cl.O=C1N[C@H]2CNC[C@@H]2c2cccc(Cl)c21
    Show/Hide
InChI
InChI=1S/C11H11ClN2O.ClH/c12-8-3-1-2-6-7-4-13-5-9(7)14-11(15)10(6)8;/h1-3,7,9,13H,4-5H2,(H,14,15);1H/t7-,9+;/m1./s1
    Show/Hide
InChIKey
QNXFKNOHBYRJEY-JXLXBRSFSA-N
Physicochemical Property
logP
1.5606
Rotatable Bonds
0
Heavy Atom Count
16
Polar Areas
41.13
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 69055626
SID: 163511197
ChEMBL ID
CHEMBL2337493
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 124 nM
   TI
   LI
   LO
   TS
2
Ki = 258 nM
   TI
   LI
   LO
   TS
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 31 nM
   TI
   LI
   LO
   TS
2
Ki = 40 nM
   TI
   LI
   LO
   TS
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 2.6 nM
   TI
   LI
   LO
   TS
2
Ki = 73 nM
   TI
   LI
   LO
   TS